Wraser Pharms Company Profile
✉ Email this page to a colleague
What is the competitive landscape for WRASER PHARMS, and what generic and branded alternatives to WRASER PHARMS drugs are available?
WRASER PHARMS has two approved drugs.
Drugs and US Patents for Wraser Pharms
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Wraser Pharms | CETRAXAL | ciprofloxacin hydrochloride | SOLUTION/DROPS;OTIC | 021918-001 | May 1, 2009 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Wraser Pharms Llc | ACETAMINOPHEN, CAFFEINE, AND DIHYDROCODEINE BITARTRATE | acetaminophen; caffeine; dihydrocodeine bitartrate | CAPSULE;ORAL | 040688-001 | Apr 3, 2007 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.